Research Article

Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF Rats

Table 1

Animal and serum characteristics.

SEDEXn3PUFA-SEDn3PUFA+EX

Final body weight (g) 6 1 7 . 1 ± 2 0 . 0 a 4 6 2 . 0 ± 1 0 . 5 b 5 7 1 . 6 ± 1 0 . 3 c 5 1 2 . 1 ± 1 7 . 5 d
Body fat (%) 3 1 . 9 ± 0 . 9 a 1 1 . 3 ± 1 . 6 b 2 9 . 5 ± 1 . 1 a 1 8 . 8 ± 1 . 3 c
Fat pad mass (g) 3 3 . 1 ± 2 . 0 a 9 . 2 ± 1 . 6 b 2 6 . 4 ± 1 . 7 c 1 6 . 4 ± 1 . 8 d
Food intake (g) 2 2 8 . 2 ± 7 . 5 a 1 9 2 . 2 ± 4 . 0 b 2 2 6 . 6 ± 5 . 8 a 1 7 8 . 5 ± 3 . 2 b
Food wt (g)/BW (g) 0 . 4 0 ± 0 . 0 0 a 0 . 4 5 ± 0 . 0 1 b 0 . 4 0 ± 0 . 0 0 a 0 . 3 9 ± 0 . 0 1 a
Caloric intake (kcal) 9 4 7 . 0 ± 3 1 . 0 a 7 9 7 . 8 ± 1 6 . 7 b 8 5 3 . 2 ± 2 1 . 9 b 6 7 2 . 1 ± 1 1 . 9 c
Calories (kcal)/BW (g) 1 . 6 7 ± 0 . 0 1 a 1 . 8 4 ± 0 . 0 5 b 1 . 5 2 ± 0 . 0 2 c 1 . 4 8 ± 0 . 0 3 c
Triglycerides (mg/dL) 1 2 3 . 7 ± 1 7 . 6 a 6 2 . 1 ± 9 . 4 b 5 9 . 4 ± 5 . 4 b 3 6 . 9 ± 4 . 6 b
Free fatty acids (μmol/L) 4 2 2 . 6 ± 3 8 . 4 a 1 9 9 . 3 ± 2 5 . 8 b 2 6 3 . 0 ± 2 5 . 3 b 1 9 3 . 4 ± 2 6 . 5 b
Glucose (mg/dL) 3 9 6 . 0 ± 1 4 . 1 a 2 5 5 . 9 ± 1 6 . 0 b 3 1 1 . 9 ± 4 5 . 1 b 2 3 9 . 2 ± 1 4 . 5 b
Insulin (ng/mL) 1 5 . 0 ± 1 . 9 a 1 0 . 0 ± 1 . 3 b 1 1 . 8 ± 1 . 6 a,b 7 . 6 ± 0 . 9 b
Heart wt/body wt (mg/g) 2 . 5 ± 0 . 1 0 a 3 . 5 ± 0 . 0 1 b 2 . 7 ± 0 . 1 0 a 3 . 1 ± 0 . 1 0 b

Values are means ± SE ( 𝑛 = 8 ). Values with different letter superscripts are significantly different from each other ( 𝑃 < 0 . 0 5 ). Fat pad mass: omental + retroperitoneal fat pads; BW: body weight.